Back to Trades
Sachs David C.
Chief Financial OfficerCIK 0001848899
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Sachs David C., Chief Financial Officer, has filed 3 SEC reports (2026), all concentrated in ImmunityBio, Inc. (IBRX), totaling $506.0K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Feb 24 | IBRX ImmunityBio, Inc. | Sachs David C. | Chief Financial Officer | Exercise | $179.9K |
| Feb 12 | IBRX ImmunityBio, Inc. | Sachs David C. | Chief Financial Officer | Exercise | $295.5K |
| Jan 5 | IBRX ImmunityBio, Inc. | Sachs David C. | Chief Financial Officer | Exercise | $30.6K |
3 filings